| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2007, p. 2608-2610, Vol. 51, No. 7
0066-4804/07/$08.00+0 doi:10.1128/AAC.00173-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, Spain
Received 6 February 2007/ Returned for modification 23 March 2007/ Accepted 6 April 2007
In a murine model of blastoschizomycosis, amphotericin B combined with micafungin, flucytosine or voriconazole did not improve the efficacy of fluconazole. However, such combinations can constitute therapeutic options for those cases where fluconazole fails.
Published ahead of print on 23 April 2007.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |